USANA Health Sciences Files 2024 10-K
Ticker: USNA · Form: 10-K · Filed: 2025-03-12T00:00:00.000Z
Sentiment: neutral
Topics: 10-K, annual-report, financials
TL;DR
USANA 10-K filed: Full FY24 financials and biz details out. Check it.
AI Summary
USANA Health Sciences Inc. filed its 2024 10-K on March 12, 2025, reporting on its fiscal year ending December 28, 2024. The company, based in Salt Lake City, UT, operates in the medicinal chemicals and botanical products sector. Key financial data and operational details for the fiscal year 2024 are presented in this annual report.
Why It Matters
This filing provides investors and stakeholders with a comprehensive overview of USANA's financial performance, strategic initiatives, and risk factors for the fiscal year 2024, crucial for evaluating the company's health and future prospects.
Risk Assessment
Risk Level: medium — As a publicly traded company in the health and wellness sector, USANA faces inherent risks related to market competition, regulatory changes, and consumer demand.
Key Numbers
- 2024 — Fiscal Year End (The report covers the fiscal year ending December 28, 2024.)
- 2025-03-12 — Filing Date (The 10-K was filed on this date.)
Key Players & Entities
- USANA Health Sciences Inc. (company) — Filer of the 10-K report
- 2024-12-28 (date) — Fiscal year end date for the report
- 2025-03-12 (date) — Filing date of the 10-K
- Salt Lake City, UT (location) — Company headquarters location
- Medicinal Chemicals & Botanical Products (industry) — Company's Standard Industrial Classification
FAQ
What were the total revenues for USANA Health Sciences in the fiscal year ending December 28, 2024?
The provided text does not contain specific revenue figures for the fiscal year ending December 28, 2024. It indicates the filing date and fiscal year end but not the financial results.
What is the company's primary business segment?
The company is classified under 'Medicinal Chemicals & Botanical Products' with SIC code 2833.
Where is USANA Health Sciences headquartered?
The company is headquartered at 3838 West Parkway Blvd., Salt Lake City, UT 84120-6336.
When was the company formerly known as USANA Inc.?
The company's name changed from USANA Inc. on January 25, 1993.
What is the SEC file number for this filing?
The SEC file number for this 10-K filing is 001-35024.
From the Filing
0000896264-25-000092.txt : 20250312 0000896264-25-000092.hdr.sgml : 20250312 20250312153614 ACCESSION NUMBER: 0000896264-25-000092 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 113 CONFORMED PERIOD OF REPORT: 20241228 FILED AS OF DATE: 20250312 DATE AS OF CHANGE: 20250312 FILER: COMPANY DATA: COMPANY CONFORMED NAME: USANA HEALTH SCIENCES INC CENTRAL INDEX KEY: 0000896264 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 870500306 STATE OF INCORPORATION: UT FISCAL YEAR END: 1228 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-35024 FILM NUMBER: 25731492 BUSINESS ADDRESS: STREET 1: 3838 WEST PARKWAY BLVD. CITY: SALT LAKE CITY STATE: UT ZIP: 84120-6336 BUSINESS PHONE: 8019547100 MAIL ADDRESS: STREET 1: 3838 WEST PARKWAY BLVD. STREET 2: 3838 WEST PARKWAY BLVD. CITY: SALT LAKE CITY STATE: UT ZIP: 84120-6336 FORMER COMPANY: FORMER CONFORMED NAME: USANA INC DATE OF NAME CHANGE: 19930125 10-K 1 usna-20241228.htm 10-K usna-20241228 0000896264 FY false 2023 P3Y http://fasb.org/us-gaap/2024#OtherAssetsNoncurrent http://fasb.org/us-gaap/2024#OtherAssetsNoncurrent http://fasb.org/us-gaap/2024#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2024#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent iso4217:USD xbrli:shares iso4217:USD xbrli:shares usna:segment xbrli:pure usna:region utr:Y usna:customer 0000896264 2023-12-31 2024-12-28 0000896264 2024-06-28 0000896264 2025-03-07 0000896264 2024-09-29 2024-12-28 0000896264 2024-12-28 0000896264 2023-12-30 0000896264 usna:LocalLineOfCreditMember 2023-12-30 0000896264 2023-01-01 2023-12-30 0000896264 2022-01-02 2022-12-31 0000896264 us-gaap:CommonStockMember 2022-01-01 0000896264 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 0000896264 us-gaap:RetainedEarningsMember 2022-01-01 0000896264 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 0000896264 2022-01-01 0000896264 us-gaap:RetainedEarningsMember 2022-01-02 2022-12-31 0000896264 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-02 2022-12-31 0000896264 us-gaap:AdditionalPaidInCapitalMember 2022-01-02 2022-12-31 0000896264 us-gaap:CommonStockMember 2022-01-02 2022-12-31 0000896264 us-gaap:CommonStockMember 2022-12-31 0000896264 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0000896264 us-gaap:RetainedEarningsMember 2022-12-31 0000896264 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0000896264 2022-12-31 0000896264 us-gaap:RetainedEarningsMember 2023-01-01 2023-12-30 0000896264 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-12-30 0000896264 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-12-30 0000896264 us-gaap:CommonStockMember 2023-01-01 2023-12-30 0000896264 us-gaap:CommonStockMember 2023-12-30 0000896264 us-gaap:AdditionalPaidInCapitalMember 2023-12-30 0000896264 us-gaap:RetainedEarningsMember 2023-12-30 0000896264 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-30 0000896264 us-gaap:RetainedEarningsMember 2023-12-31 2024-12-28 0000896264 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 2024-12-28 0000896264 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 2024-12-28 0000896264 us-gaap:CommonStockMember 2023-12-31 2024-12-28 0000896264 us-gaap:CommonStockMember 2024-12-28 0000896264 us-gaap:AdditionalPaidInCapitalMember 2024-12-28 0000896264 us-gaap:RetainedEarningsMember 2024-12-28 0000896264 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-12-28 0000896264 usna:HiyaMember 2024-12-23 0000896264 us-gaap:MoneyMarketFundsMember us-gaap:FairValueMeasurementsRecurringMember 2024-12-28 0000896264 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2024-12-28 0000896264 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2024-12-28 0000896264 us